Ranchi– In a heartbreaking breach of medical trust, five thalassemia-afflicted children in Jharkhand’s West Singhbhum district have tested HIV-positive after receiving contaminated blood transfusions at Chaibasa Sadar Hospital, exposing glaring lapses in the state’s blood safety protocols. The incident, which first surfaced on October 24 when a seven-year-old’s family raised alarms of negligence, has prompted swift government action—including suspensions, financial aid, and high-level investigations—but experts warn that without mandatory advanced testing and stricter regulations, such tragedies could recur, endangering vulnerable patients nationwide.
The cases, all involving repeated transfusions for the genetic blood disorder thalassemia, have shattered families and ignited public fury. “Our child was fighting for life, not for infection,” wailed the mother of one victim, accusing hospital staff of “careless treatment” in sourcing unverified blood units. Four more children were confirmed positive shortly after, prompting Chief Minister Hemant Soren to intervene decisively on October 26. In a bid to trace the source, authorities are now scrambling to contact 256 donors whose blood may have been used in recent months, a herculean task amid fragmented records.
Swift Suspensions and Support: Holding the Line on Accountability
The Jharkhand government moved rapidly to stem the fallout. Soren ordered the immediate suspension of the West Singhbhum Civil Surgeon, the hospital’s blood bank in-charge, and a medical officer, citing “deadly negligence” in screening procedures. Health Minister Irfan Ansari announced Rs 2 lakh in ex-gratia payment for each affected family, along with full coverage of lifelong antiretroviral therapy costs, emphasizing, “No child should pay for systemic failures.” A high-powered probe committee, led by the state health secretary, was constituted to audit transfusion records and donor verification logs, with preliminary findings expected within a week.
Complementing state efforts, a five-member central investigation team from the Union Health Ministry descended on Chaibasa’s Mahatma Gandhi Memorial (MGM) Hospital on October 28, conducting surprise inspections of the blood bank. The team scrutinized registers, equipment, and compliance with the Drugs and Cosmetics Act, 1940, issuing directives for immediate online uploads to the national portal. This visit underscores Delhi’s growing oversight, especially after similar scares in other states.
Statewide Rot: Unlicensed Banks and Raids Expose Deeper CrisisThe Chaibasa horror is no isolated lapse. A damning audit revealed that blood banks in nine districts—including Jamshedpur, Khunti, Garhwa, Bokaro, Lohardaga, Latehar, Koderma, and Gumla—have been operating on expired licenses for months, flouting mandatory renewals under Form 27-C. In Jamshedpur’s MGM facility alone, renewal applications linger unresolved despite central team interventions, raising fears of unchecked viral transmissions.
Echoing this urgency, Dhanbad Deputy Commissioner Aditya Ranjan led a shock raid on the blood bank at Shaheed Nirmal Mahto Medical College and Hospital on October 29, grilling staff on collection, testing, and storage protocols. Issuing stern warnings against any “laxity,” he mandated daily reports to the district control room and round-the-clock monitoring to ensure ELISA/CLIA tests are tamper-proof. “One drop of negligence could cost lives,” Ranjan declared, vowing FIRs for violations.
These crackdowns form part of a broader post-incident sweep, with opposition parties slamming the Hemant Soren regime for a “failing health apparatus” that prioritizes replacement donations over voluntary ones, as per the National Blood Policy.
Bridging the Gaps: Can NAT Testing and Reforms Stave Off Future Nightmares?
At the scandal’s core lies a glaring void: the absence of Nucleic Acid Testing (NAT), the gold-standard screen for HIV and hepatitis during the critical “window period” when standard ELISA tests falter. Jharkhand’s blood banks, often under-resourced and disconnected from the e-RaktKosh digital platform, lack donor traceability systems, making post-donation alerts impossible. Thalassemia patients, pregnant women, and ICU wards bear the brunt, with residual infection risks hovering at 1 in 1 lakh units without NAT—far from the near-zero achievable with it.
Government insiders hint at upcoming mandates: universal NAT for high-risk transfusions, barcoding every blood bag, and NABH accreditation for all 50+ state banks by mid-2026. Integration with e-RaktKosh for real-time tracking and a dedicated Blood Transfusion Policy could seal these fissures, experts argue. “These aren’t optional; they’re lifelines,” says Dr. A.K. Srivastava, former RIMS pathology head, stressing that licensed operations ensure trained staff and certified gear.
Yet, as probes unfold and families grapple with irreversible trauma, the million-dollar question lingers:
Will Jharkhand’s reactive resolve translate to proactive safeguards? With central backing and public pressure mounting, the state stands at a crossroads—poised to either fortify its veins against invisible threats or risk more innocent blood on its hands. For now, the suspended officials and sealed ledgers signal intent; only time—and unyielding enforcement—will prove if it’s enough.
Source : Inputs From New Indian Express, Indian Express, ND TV
